Reuters logo
BRIEF-Acorda Therapeutics entered into settlement agreement with Apotex Corp, Apotex Inc on Feb. 8
February 10, 2017 / 12:57 PM / 10 months ago

BRIEF-Acorda Therapeutics entered into settlement agreement with Apotex Corp, Apotex Inc on Feb. 8

Feb 10 (Reuters) - Acorda Therapeutics Inc :

* Acorda Therapeutics Inc - on Feb 8, 2017, Acorda Therapeutics, inc entered into settlement agreement with Apotex Corporation and Apotex Inc-sec filing

* Acorda Therapeutics- as result of settlement agreement, co will be permitted to market generic version of ampyra in united states at specified date in 2025

* Acorda Therapeutics Inc - settlement to resolve pending patent litigation brought by company against Apotex involving ampyra extended-release tablets

* Acorda Therapeutics - parties will request court enter consent order, in which it will dismiss company’s litigation against apotex referred to above

* Acorda Therapeutics Inc - details of settlement are confidential Source text f(bit.ly/2kzYpT9) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below